Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-06

Clinical Trial Update: Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating buprenorphine detoxification using two treatment approaches for opioid use disorder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED